SWOG clinical trial number
SWOG-8830
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Ovarian Cancer
Closed
Phase
Accrual
10%
Abbreviated Title
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Ovarian Cancer
Activated
04/01/1989
Closed
11/15/1990